Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next‐generation sequencing in Ramathibodi Hospital, Mahidol University

Author:

Oranratnachai Songporn1ORCID,Yamkaew Watchalawalee1,Tunteeratum Atchara2,Sukarayothin Thongchai3ORCID,Iemwimangsa Nareenart4,Panvichien Ravat1ORCID

Affiliation:

1. Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

2. Division of Medical Genetics, Department of Medicine, Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

3. Breast and Endocrine Surgery Unit, Department of Surgery, Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

4. Center for Medical Genomics Ramathibodi Hospital Mahidol University Bangkok Thailand

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. World Health Organization.Thailand—global cancer observatory 20202020Available fromhttps://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf(Accessed May 1 2021).

3. BRCA1 and BRCA2: different roles in a common pathway of genome protection

4. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

5. BRCA1 mutation in breast cancer patients: analysis of prognostic factors and survival;Huszno J;Oncol Lett,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3